NCT01923025View on ClinicalTrials.gov

A PET Study With RO5545965 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Schizophrenia

Interventions

DRUG

RO5545965

Single dose

Trial Locations (1)

NW10 7EW

London

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01923025 - A PET Study With RO5545965 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter